CD8A and ovarian cancer: In summary, our study provides evidence that intraepithelial infiltration of ovarian carcinomas by CD8-positive T lymphocytes is prognostic for improved survival in optimally debulked, stage III ovarian cancer patients, most significantly also for those with the option of adjuvant paclitaxel/carboplatin therapy.